Phibro Animal Health Co. to Post FY2024 Earnings of $1.12 Per Share, Zacks Research Forecasts (NASDAQ:PAHC)

Phibro Animal Health Co. (NASDAQ:PAHC) – Analysts at Zacks Research lowered their FY2024 earnings per share estimates for Phibro Animal Health in a research report issued to clients and investors on Tuesday, July 23rd. Zacks Research analyst R. Department now expects that the company will post earnings per share of $1.12 for the year, down from their previous estimate of $1.13. The consensus estimate for Phibro Animal Health’s current full-year earnings is $1.13 per share.

Phibro Animal Health (NASDAQ:PAHC) last issued its quarterly earnings data on Wednesday, May 8th. The company reported $0.31 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.29 by $0.02. The company had revenue of $263.20 million for the quarter, compared to analyst estimates of $251.82 million. Phibro Animal Health had a return on equity of 17.11% and a net margin of 1.32%.

Several other equities research analysts also recently weighed in on PAHC. Barclays increased their target price on shares of Phibro Animal Health from $10.00 to $13.00 and gave the stock an “underweight” rating in a research note on Friday, May 10th. StockNews.com upgraded shares of Phibro Animal Health from a “hold” rating to a “buy” rating in a research note on Tuesday, April 9th. Two research analysts have rated the stock with a sell rating, one has given a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat, Phibro Animal Health currently has a consensus rating of “Hold” and an average price target of $14.75.

Phibro Animal Health Stock Performance

Shares of PAHC stock opened at $18.83 on Friday. The stock’s 50-day moving average is $17.74 and its two-hundred day moving average is $14.65. The firm has a market cap of $762.62 million, a price-to-earnings ratio of 58.85, a PEG ratio of 4.90 and a beta of 0.57. Phibro Animal Health has a 1 year low of $9.40 and a 1 year high of $19.55. The company has a debt-to-equity ratio of 1.69, a quick ratio of 1.67 and a current ratio of 3.16.

Phibro Animal Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, June 26th. Investors of record on Wednesday, June 5th were given a $0.12 dividend. The ex-dividend date was Wednesday, June 5th. This represents a $0.48 dividend on an annualized basis and a yield of 2.55%. Phibro Animal Health’s payout ratio is currently 150.00%.

Institutional Investors Weigh In On Phibro Animal Health

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Illinois Municipal Retirement Fund lifted its position in shares of Phibro Animal Health by 7.2% during the 1st quarter. Illinois Municipal Retirement Fund now owns 11,430 shares of the company’s stock valued at $148,000 after acquiring an additional 765 shares during the period. CWM LLC lifted its position in shares of Phibro Animal Health by 89.8% during the 2nd quarter. CWM LLC now owns 2,188 shares of the company’s stock valued at $37,000 after acquiring an additional 1,035 shares during the period. Price T Rowe Associates Inc. MD lifted its position in shares of Phibro Animal Health by 7.4% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 15,393 shares of the company’s stock valued at $200,000 after acquiring an additional 1,063 shares during the period. Nisa Investment Advisors LLC lifted its position in shares of Phibro Animal Health by 19.2% during the 4th quarter. Nisa Investment Advisors LLC now owns 8,500 shares of the company’s stock valued at $98,000 after acquiring an additional 1,370 shares during the period. Finally, China Universal Asset Management Co. Ltd. lifted its position in shares of Phibro Animal Health by 65.0% during the 1st quarter. China Universal Asset Management Co. Ltd. now owns 3,888 shares of the company’s stock valued at $50,000 after acquiring an additional 1,531 shares during the period. 99.34% of the stock is currently owned by institutional investors and hedge funds.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.